Coyle Institute
Coyle Institute is a private Pensacola, Florida urogynecology and pelvic health medical practice founded in 2004, serving women with pelvic floor disorders, incontinence, lichen sclerosus, and hormone-related conditions through advanced laser, robotic, and proprietary procedures including the trademarked TULIP® treatment.
- Company typePrivate
- Founded2004
- HeadquartersPensacola, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Coyle Institute does
Coyle Institute is a private, single-site urogynecology and pelvic health medical practice founded in 2004 by Dr. Michael Coyle in Pensacola, Florida. It is structured as a direct-to-consumer specialty clinic that treats women with pelvic floor disorders, urinary and fecal incontinence, pelvic organ prolapse, lichen sclerosus, vaginal atrophy, sexual dysfunction, chronic pelvic pain, and hormone-related conditions. The practice combines minimally invasive robotic surgery (da Vinci system) and FDA-cleared neurostimulation (InterStim®) with a suite of in-office, non-surgical procedures including the proprietary TULIP® protocol (ProFractional laser plus PRP), Sciton's diVa® and diVaTyte™ laser vaginal therapies, BBL™ facial rejuvenation, the O-Shot®, Prolozone and ozone IV therapy, bioidentical hormone replacement therapy, and colon hydrotherapy.
The underlying technology stack is device-led rather than software-led: Sciton laser platforms, Intuitive Surgical robotic systems, Medtronic and Coloplast implants, and PRP preparation workflows, with the Athena Health patient portal as the only notable software integration. Business model is professional-services fee-for-service with quote-based pricing, a downloadable BHRT price sheet, and a deliberate cash-pay mix (Prolozone and several elective procedures are not broadly insurance-reimbursed). The go-to-market relies on content marketing (website, blog archives from 2015, educational video), direct appointment booking, and a medical tourism program that draws patients nationally and internationally for the three-day TULIP® visit.
The practice is founder-centric: Dr. Coyle, the first U.S. board-certified Female Pelvic Medicine and Reconstructive Surgeon (FPMRS) and a former national trainer for Intuitive Surgical, Medtronic, and Coloplast, is supported by an ARNP (Amy Stone) and a small (11–50) employee base. There is no disclosed external funding, no parent company, and no subsidiaries.
Coyle Institute firmographics
Firmographics- Name
- Coyle Institute
- Legal name
- Coyle Institute
- Website
- https://coyleinstitute.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Coyle Institute is a private Pensacola, Florida urogynecology and pelvic health medical practice founded in 2004, serving women with pelvic floor disorders, incontinence, lichen sclerosus, and hormone-related conditions through advanced laser, robotic, and proprietary procedures including the trademarked TULIP® treatment.
- Ownership category
- akta.pro rank
Coyle Institute industry classification
Industry- Product category
- Urogynecology and Pelvic Health Services
- akta.pro primary industry
- Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine) (HLAKAJAE)
Keywords
Where Coyle Institute is headquartered
LocationHeadquarters
- HQ city
- Pensacola
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Coyle Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Medical Consultation and Procedure Fees: Revenue generated from office consultations, diagnostic evaluations, and medical procedures including TULIP®, diVa®, O-Shot®, BBL treatments, hormone therapy, and surgical procedures. The practice offers both one-time procedures and ongoing treatment protocols.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Bioidentical Hormone Replacement Therapy (BHRT) |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Coyle Institute product offering
Product offeringCore offering
Coyle Institute is a urogynecology and pelvic health medical practice delivering both surgical and non-surgical women's health treatments. Core offerings include the proprietary TULIP® procedure for lichen sclerosus, diVa® laser vaginal rejuvenation, O-Shot® PRP therapy, BBL™ facial rejuvenation, bioidentical hormone replacement therapy (BHRT), Prolozone and Ozone IV regenerative therapies, colon hydrotherapy, and minimally invasive surgeries including da Vinci robotic procedures and InterStim® neurostimulation.
Product overview
Coyle Institute is a urogynecology and pelvic health medical practice offering a comprehensive portfolio of both surgical and non-surgical treatment services. The core offerings include: diVa® and diVaTyte™ laser vaginal therapies (Sciton HFL technology) for vaginal rejuvenation; BBL™ facial rejuvenation; O-Shot® PRP procedures; the proprietary TULIP® treatment for lichen sclerosus; ozone IV and Prolozone injection therapies; bioidentical hormone replacement therapy (BHRT); colon hydrotherapy; and surgical procedures including da Vinci robotic surgery, labiaplasty, and InterStim® device implantation. The practice specializes in treating pelvic organ prolapse, urinary/fecal incontinence, endometriosis, fibroids, interstitial cystitis, and other pelvic floor disorders. The treatments range from non-invasive in-office procedures to minimally invasive surgeries.
Differentiator
Problem solved
Functional benefit
Brands
- TULIP®: A groundbreaking treatment for lichen sclerosus developed by Dr. Michael Coyle, using ProFractional™ laser and Platelet Rich Plasma (PRP) therapy.
- diVa®
- O-Shot®
- BBL™
- diVaTyte™
Products and services
- TULIP® Treatment for Lichen Sclerosus Proprietary in-office procedure for women with lichen sclerosus and lichen simplex chronicus that combines ProFractional™ laser ablation with PRP to eliminate damaged tissue and stimulate regeneration, with reported 100% symptom recovery after a single procedure.
- diVa® Vaginal Rejuvenation Laser vaginal therapy using Hybrid Fractional Laser (HFL) to resurface vaginal walls, stimulate collagen, and address vaginal atrophy, laxity, and mild urinary incontinence in women.
- diVaTyte™ (SkinTyte™) Laser Vaginal Therapy Non-invasive laser therapy using infrared energy and BBL technology to improve labial and vulvar skin appearance by stimulating collagen and elastin regeneration.
- BBL™ (BroadBand Light) Facial Rejuvenation Laser facial rejuvenation using Sciton BBL technology to treat sun damage, age spots, freckles, rosacea, acne, and signs of aging in women.
- O-Shot® Female sexual enhancement and urinary incontinence treatment using platelet-rich plasma (PRP) injections derived from the patient's own blood to rejuvenate vaginal and clitoral function and improve arousal and orgasms.
- Ozone IV Therapy Intravenous ozone therapy using Major Auto-Hemotherapy (MAH) to promote healing, immune regulation, circulation, and mitochondrial stimulation as adjunctive treatment for urogynecological conditions.
- Prolozone Therapy Regenerative injection therapy combining ozone (O₃) with nutrients injected at the site of pain to reduce inflammation and stimulate healing for pelvic, bladder and joint pain.
- Bioidentical Hormone Replacement Therapy (BHRT) Hormone therapy using bioidentical hormones prescribed as transdermal creams based on lab testing and ongoing monitoring to address hormonal imbalances during perimenopause and menopause.
- Colon Hydrotherapy Safe colon cleansing procedure using warm filtered water to hydrate the colon, soften and eliminate waste, and support gut health and immune function.
- Labiaplasty Surgical reduction of the labia minora using trim or wedge procedures to reduce discomfort, improve hygiene, and address cosmetic concerns.
- Da Vinci Robotic Surgery Minimally invasive robotic-assisted surgery using the da Vinci Surgical System for hysterectomy, myomectomy, pelvic reconstruction, and sacrocolpopexy.
- InterStim® Therapy FDA-approved sacral nerve neurostimulation therapy involving device implantation for the treatment of fecal and urinary incontinence.
Quantifiable outcome
- Patients report 100 percent recovery from all lichen sclerosus symptoms following a single TULIP® procedure
- +3 more outcomes
Companies that use Coyle Institute
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Coyle Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Coyle Institute partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Intuitive SurgicalcoreDr. Coyle served as a National Trainer and Proctor for Intuitive Surgical, training surgeons nationwide in the use of the Da Vinci Surgical System for minimally invasive and robotic surgery.
- Sciton, Inc.coreProvider of diVa® Hybrid Fractional Laser technology and BBL™ (BroadBand Light) systems. Coyle Institute providers are BBL™ trained through Sciton, one of the leading innovators in medical BBL™ technologies.
Scale indicators4 records
Recent moves7 records
Expansion highlights4 records
Coyle Institute competitors and assessment
Company assessmentDirect peers
- BioTE Medical: BioTE Medical is a hormone optimization franchise with a national provider network offering bioidentical hormone replacement therapy on a cash-pay, D2C basis. Operates a near-identical cash-pay, women's-health anti-aging model to Coyle Institute's BHRT service.
- Defy Medical: Defy Medical is a direct-to-consumer telehealth and clinic-based practice specializing in hormone replacement, peptides, and wellness therapies. Its model overlaps directly with Coyle Institute's cash-pay hormone and wellness offering, although national in reach.
Broad incumbents
- Cleveland Clinic – Female Pelvic Medicine & Reconstructive Surgery: Cleveland Clinic operates a major Female Pelvic Medicine and Reconstructive Surgery program covering the same urogynecology/female pelvic medicine subspecialty that Coyle Institute focuses on, but as part of a large academic health system with insurance-led reimbursement.
- Weill Cornell Medicine – Female Pelvic Medicine & Reconstructive Surgery: Weill Cornell Medicine runs an academic FPMRS division providing urogynecology and pelvic reconstructive surgery services overlapping directly with Coyle Institute's clinical focus but at much larger scale and as part of a multi-specialty hospital.
- Atlantic Health System – Urogynecology: Atlantic Health System runs multi-site urogynecology centers across northern New Jersey. Overlaps with Coyle Institute's urogynecology and pelvic floor focus area but operates at system scale with insurance-based reimbursement.
- Hologic (Mona Lisa Touch / TempSure Vitalia): Hologic markets the Mona Lisa Touch and TempSure Vitalia laser/RF platforms for vaginal rejuvenation, directly competing with Sciton's diVa® used by Coyle Institute. It is a large incumbent in the energy-based gynecology device category.
Emerging players
- InMode (Votiva / Morpheus8 V): InMode sells the Votiva and Morpheus8 V systems for feminine health and vaginal rejuvenation, competing directly against the diVa® laser platform used by Coyle Institute. Emerging player in clinic-deployed aesthetic gynecology devices.
- Thermi (Almirall) – ThermiVa: Almirall's Thermi brand markets the ThermiVa RF system for non-surgical vaginal rejuvenation, an alternative to the diVa® laser offering at Coyle Institute. Smaller, focused competitor in the same device category.
Others
- Sciton: Sciton is the manufacturer of the diVa® Hybrid Fractional Laser and BBL™ platforms used by Coyle Institute. Functions as the primary technology enablement partner rather than a direct competitor.
- Intuitive Surgical: Intuitive Surgical is the manufacturer of the da Vinci Surgical System used by Coyle Institute for minimally invasive urogynecological procedures. Serves as a technology enabler and training partner rather than a clinical competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Coyle Institute social profiles
Digital presenceCoyle Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Coyle Institute leadership team
Management profileNumber of profiles
Profiles2 records
Coyle Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Coyle Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Coyle Institute
What does Coyle Institute do?
Coyle Institute is a urogynecology and pelvic health medical practice delivering both surgical and non-surgical women's health treatments. Core offerings include the proprietary TULIP® procedure for lichen sclerosus, diVa® laser vaginal rejuvenation, O-Shot® PRP therapy, BBL™ facial rejuvenation, bioidentical hormone replacement therapy (BHRT), Prolozone and Ozone IV regenerative therapies, colon hydrotherapy, and minimally invasive surgeries including da Vinci robotic procedures and InterStim® neurostimulation.
Is Coyle Institute a public or private company?
Coyle Institute is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Coyle Institute founded?
Coyle Institute was founded in 2004. It employs 11 to 50 people.
Where is Coyle Institute based?
Coyle Institute is headquartered in Pensacola, United States, in the North America region.
How does Coyle Institute make money?
One revenue line is on record: medical Consultation and Procedure Fees.
Who are Coyle Institute's main competitors?
Direct peers on record are BioTE Medical and Defy Medical. Broad incumbents are Cleveland Clinic – Female Pelvic Medicine & Reconstructive Surgery, Weill Cornell Medicine – Female Pelvic Medicine & Reconstructive Surgery, Atlantic Health System – Urogynecology and Hologic (Mona Lisa Touch / TempSure Vitalia). Emerging players are InMode (Votiva / Morpheus8 V) and Thermi (Almirall) – ThermiVa. Others are Sciton and Intuitive Surgical.
Does Coyle Institute have an API?
No public API is recorded for Coyle Institute.
What industry is Coyle Institute in?
Coyle Institute's product category is Urogynecology and Pelvic Health Services. Its primary akta.pro industry code is HLAKAJAE, Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine).